Treating Headache Recurrence After Emergency Department Discharge: A Randomized Controlled Trial of Naproxen Versus Sumatriptan

Annals of Emergency Medicine

Volumn 56, Issue 1, 2010, Pages 7-17

  Friedman, Benjamin W ^a   Solorzano, Clemencia ^b   Esses, David ^a   Xia, Shujun ^a   Hochberg, Michael ^a   Dua, Niels ^c   Heins, Alan ^d   Sasso, Paul ^c   Bijur, Polly E ^a   Lipton, Richard B ^a   Gallagher, E John ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; EMERGENCY WARD; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; TELEPHONE; WEAKNESS;

ADULT; ANALGESICS; DOUBLE-BLIND METHOD; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEADACHE; HUMANS; MALE; MIGRAINE DISORDERS; MIGRAINE WITHOUT AURA; NAPROXEN; PAIN MEASUREMENT; PATIENT DISCHARGE; RECURRENCE; SUMATRIPTAN; TREATMENT OUTCOME;

EID: 77953603785     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2010.02.005     Document Type: Article

References (46)

1. Bigal M., Bordini C.A., and Speciali J.G. Headache in an emergency room in Brazil. Sao Paulo Med J 118 (2000) 58-62
2. Friedman B., Hochberg m., Esses D., et al. Pain and functional outcomes of patients with primary headache disorder discharged from the emergency department [abstract]. Acad Emerg Med 13 5 suppl 1 (2006) S18
3. McCaig L.F., and Nawar E.W. National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data 372 (2006) 1-29
4. Friedman B.W., and Grosberg B.M. Diagnosis and management of the primary headache disorders in the emergency department setting. Emerg Med Clin North Am 27 (2009) 71-87, viii
5. Schwartz B.S., Stewart W.F., Simon D., et al. Epidemiology of tension-type headache. JAMA 279 (1998) 381-383
6. Lipton R.B., Bigal M.E., Diamond M., et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68 (2007) 343-349
7. Vinson D.R. Treatment patterns of isolated benign headache in US emergency departments. Ann Emerg Med 39 (2002) 215-222
8. Akpunonu B.E., Mutgi A.B., Federman D.J., et al. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Ann Emerg Med 25 (1995) 464-469
9. Bigal M.E., Bordini C.A., and Speciali J.G. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med 23 (2002) 141-148
10. Cete Y., Dora B., Ertan C., et al. A randomized prospective placebo-controlled study of intravenous magnesium sulphate versus metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia 25 (2005) 199-204
11. Corbo J., Esses D., Bijur P.E., et al. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 38 (2001) 621-627
12. Ducharme J., Beveridge R.C., Lee J.S., et al. Emergency management of migraine: is the headache really over?. Acad Emerg Med 5 (1998) 899-905
13. Friedman B.W., Corbo J., Lipton R.B., et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 64 (2005) 463-468
14. Carleton S.C., Shesser R.F., Pietrzak M.P., et al. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med 32 (1998) 129-138
15. Cameron J.D., Lane P.L., and Speechley M. Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache. Acad Emerg Med 2 (1995) 597-602
16. Miner J.R., Fish S., Smith S.W., et al. Droperidol versus prochlorperazine for benign headaches in the emergency department. Acad Emerg Med 8 (2001) 873-879
17. Tfelt-Hansen P., Block G., Dahlof C., et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 20 (2000) 765-786
18. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 24 suppl 1 (2004) 1-151
19. Friedman B.W., Hochberg M.L., Esses D., et al. Applying the International Classification of Headache Disorders to the emergency department: an assessment of reproducibility and the frequency with which a unique diagnosis can be assigned to every acute headache presentation. Ann Emerg Med 49 (2007) 409-419 419.e1-9
20. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
21. Andersson P.G., Hinge H.H., Johansen O., et al. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia 9 (1989) 29-32
22. Nestvold K., Kloster R., Partinen M., et al. Treatment of acute migraine attack: naproxen and placebo compared. Cephalalgia 5 (1985) 115-119
23. Lipton R.B., Steart W.F., Cady R., et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 40 (2000) 783-791
24. Miner J., Bursell B., and Smith S. Sumatriptan for the treatment of benign headaches in the emergency department [abstract]. J Acad Emerg Med 11 (2004) 541
25. Bijur P.E., Latimer C.T., and Gallagher E.J. Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Acad Emerg Med 10 (2003) 390-392
26. Friedman B.W., Hochberg M., Esses D., et al. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines. Headache 46 (2006) 934-941
27. Kelly A.M. Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?. Acad Emerg Med 5 (1998) 1086-1090
28. Pascual J., Mateos V., Roag C., et al. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability. Headache 47 (2007) 1152-1168
29. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med 325 (1991) 316-321
30. Cady R.K., Ruino J., Crummett D., et al. Oral sumatriptan in the treatment of recurrent headache. Arch Fam Med 3 (1994) 766-772
31. Ferrari M.D., James M.H., Bates D., et al. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia 14 (1994) 330-338
32. Larkin G.L., and Prescott J.E. A randomized, double-blind, comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine. Ann Emerg Med 21 (1992) 919-924
33. Friedman B.W., Hochberg M.L., Esses D., et al. Recurrence of primary headache disorders after emergency department discharge: frequency and predictors of poor pain and functional outcomes. Ann Emerg Med 52 (2008) 696-704
34. Visser W.H., Jaspers N.M., de Vriend R.H., et al. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia 16 (1996) 264-269
35. Tfelt-Hansen P. What can be learned from the history of recurrence in migraine? a comment. J Headache Pain 10 (2009) 311-315
36. Colman I., Friedman B.W., Brown M.D., et al. Parenteral dexamethasone for preventing recurrent migraine headaches: a systematic review of the literature. BMJ 336 (2008) 1359-1361
37. Singh A., Alter H.J., and Zaia B. Does the addition of dexamethasone to standard therapy for acute migraine headache decrease the incidence of recurrent headache for patients treated in the emergency department? a meta-analysis and systematic review of the literature. Acad Emerg Med 15 (2008) 1223-1233
38. Krymchantowski A.V. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 58 (2000) 428-430
39. Cull R.E., Price W.H., and Dunbar A. The efficacy of subcutaneous sumatriptan in the treatment of recurrence of migraine headache. J Neurol Neurosurg Psychiatry 62 (1997) 490-495
40. Teall J., Tuchman M., Cutler M., et al. Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Headache 38 (1998) 281-287
41. Rapoport A.M., Visser W.H., Cutler N.R., et al. Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan. Neurology 45 (1995) 1505-1509
42. Brandes J.L., Kudrow D., Stark S.R., et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 297 (2007) 1443-1454
43. Smith T.R., Sunshine A., Stark S.R., et al. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45 (2005) 983-991
44. Ho T.W., Rodgers A., and Bigal M.E. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis. Headache 49 (2009) 395-403
45. Dodick D., and Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache 46 suppl 4 (2006) S202-S211
46. Bigal M.E., Serrano D., Buse D., et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48 (2008) 1157-1168